Home > Boards > US Listed > Biotechs > Nabriva Therapeutics AG (NBRV)

$NBRV apparently an unknown COVID-19 play

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BiotechValues Member Profile
 
Followed By 340
Posts 10,238
Boards Moderated 2
Alias Born 06/23/07
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/2/2021 6:31:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/2/2021 6:29:45 PM
Nabriva Therapeutics' lefamulin application accepted for review in China Seeking Alpha - 11/29/2021 9:34:46 AM
Lefamulin NDA Filed in Mainland China for Treatment of Community Acquired Pneumonia GlobeNewswire Inc. - 11/29/2021 9:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/19/2021 12:58:37 PM
Nabriva Announces Availability of XENLETA® (lefamulin) in a 10-Count Oral Pack GlobeNewswire Inc. - 11/11/2021 7:01:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 11/10/2021 4:59:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/9/2021 5:45:03 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 11/9/2021 5:38:45 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2021 4:24:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2021 4:02:23 PM
Nabriva Therapeutics EPS beats by $0.01, beats on revenue Seeking Alpha - 11/9/2021 4:02:05 PM
Nabriva Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update GlobeNewswire Inc. - 11/9/2021 4:01:00 PM
Nabriva Therapeutics Q3 2021 Earnings Preview Seeking Alpha - 11/8/2021 5:35:47 PM
Nabriva Therapeutics to Present at the Jefferies London Healthcare Conference GlobeNewswire Inc. - 11/5/2021 7:01:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/2/2021 6:05:26 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/1/2021 7:52:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/1/2021 7:50:48 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/1/2021 4:10:58 PM
Nabriva Therapeutics reports inducement grant to CMO Seeking Alpha - 11/1/2021 8:17:52 AM
Nabriva Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 11/1/2021 7:01:00 AM
Nabriva Therapeutics to Report Third Quarter 2021 Financial Results and Recent Corporate Highlights on November 9, 2021 GlobeNewswire Inc. - 10/26/2021 7:01:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 10/19/2021 4:43:24 PM
Nabriva Therapeutics to Present Data at CHEST Annual Meeting 2021 GlobeNewswire Inc. - 10/15/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2021 4:40:33 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences